Cargando…

A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma

Abnormal expression of the E3 ubiquitin ligase A20 has been found in some malignant cancers, including hepatocellular carcinoma (HCC). Here, we discovered that A20 is an E3 ubiquitin ligase for phosphofructokinase, liver type (PFKL) in HCC A20 interacts with PFKL and promotes its degradation, theref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yilu, Zhang, Ye, Cai, Yi, Liu, Ruijie, Lu, Miaolong, Li, Tangzhiming, Fu, Ying, Guo, Ming, Huang, Huichao, Ou, Yifu, Chen, Yongheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997366/ https://www.ncbi.nlm.nih.gov/pubmed/32015333 http://dx.doi.org/10.1038/s41419-020-2278-6

Ejemplares similares

Antitumor effects of the small molecule DMAMCL in neuroblastoma via suppressing aerobic glycolysis and targeting PFKL
por: Zhang, Simeng, et al.
Publicado: (2021)

Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer
por: Huang, Huichao, et al.
Publicado: (2020)

Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner
por: Zheng, Cancan, et al.
Publicado: (2022)

Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells via Quantitative Phosphoproteomics
por: Huang, Huichao, et al.
Publicado: (2020)

DNAAF5 promotes hepatocellular carcinoma malignant progression by recruiting USP39 to improve PFKL protein stability
por: Liu, Yaping, et al.
Publicado: (2022)

A functional loop between YTH domain family protein YTHDF3 mediated m(6)A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma
por: Zhou, Rong, et al.
Publicado: (2022)

Selective activation of PFKL suppresses the phagocytic oxidative burst
por: Amara, Neri, et al.
Publicado: (2021)

Suberoylanilide Hydroxamic Acid (SAHA) Treatment Reveals Crosstalk Among Proteome, Phosphoproteome, and Acetylome in Nasopharyngeal Carcinoma Cells
por: Huang, Huichao, et al.
Publicado: (2022)

PFKL, a novel regulatory node for NOX2-dependent oxidative burst and NETosis
por: CAO, Zhaohui, et al.
Publicado: (2022)

Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers
por: Li, Ke, et al.
Publicado: (2021)

ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells
por: Zhang, Xiao, et al.
Publicado: (2022)

The KLF7/PFKL/ACADL axis modulates cardiac metabolic remodelling during cardiac hypertrophy in male mice
por: Wang, Cao, et al.
Publicado: (2023)

PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma
por: Leung, Carmen Oi-ning, et al.
Publicado: (2015)

A peptide-crosslinking approach identifies HSPA8 and PFKL as selective interactors of an actin-derived peptide containing reduced and oxidized methionine
por: Maurais, Aaron, et al.
Publicado: (2022)

Cordycepin Inhibits the Growth of Hepatocellular Carcinoma by Regulating the Pathway of Aerobic Glycolysis
por: Chen, Ya, et al.
Publicado: (2022)

Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma
por: Xia, Xigang, et al.
Publicado: (2021)

CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression via Aerobic Glycolysis
por: Chen, Zhimin, et al.
Publicado: (2022)

ZC3H13 Inhibits the Progression of Hepatocellular Carcinoma through m(6)A-PKM2-Mediated Glycolysis and Enhances Chemosensitivity
por: Wang, Qibo, et al.
Publicado: (2021)

Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma
por: Cheng, Zhe, et al.
Publicado: (2023)

Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
por: Paech, Franziska, et al.
Publicado: (2017)

Sulfotransferase 1C2 promotes hepatocellular carcinoma progression by enhancing glycolysis and fatty acid metabolism
por: Jiang, Liya, et al.
Publicado: (2023)

The Significance of Serum S100A9 and TNC Levels as Biomarkers in Colorectal Cancer
por: Zhou, Minze, et al.
Publicado: (2019)

Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease
por: Riwanto, Meliana, et al.
Publicado: (2016)

TET2 suppresses nasopharyngeal carcinoma progression by inhibiting glycolysis metabolism
por: Zhang, Xixia, et al.
Publicado: (2020)

Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma
por: Pan, Yu, et al.
Publicado: (2021)

Multifaceted roles of aerobic glycolysis and oxidative phosphorylation in hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2023)

Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal Carcinoma
por: Huang, Huichao, et al.
Publicado: (2022)

Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2
por: Xu, Dong, et al.
Publicado: (2017)

The roles of glycolysis in osteosarcoma
por: Feng, Zuxi, et al.
Publicado: (2022)

GBE1 Promotes Glioma Progression by Enhancing Aerobic Glycolysis through Inhibition of FBP1
por: Chen, Zhen, et al.
Publicado: (2023)

Inhibition of Glycolysis Suppresses Cell Proliferation and Tumor Progression In Vivo: Perspectives for Chronotherapy
por: Horváthová, Jana, et al.
Publicado: (2021)

Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression
por: Wang, Jianqun, et al.
Publicado: (2021)

LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation
por: Chen, Bin, et al.
Publicado: (2023)

Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
por: DeWaal, Dannielle, et al.
Publicado: (2018)

PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition
por: Yang, Yang, et al.
Publicado: (2022)

FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma
por: Lei, Shixiong, et al.
Publicado: (2016)

Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
por: Feng, Jiao, et al.
Publicado: (2020)

Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by inhibiting glycolysis
por: Chen, Zhitao, et al.
Publicado: (2023)

Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma
por: Zheng, Ju-Yan, et al.
Publicado: (2022)

Identification and Validation of a Novel Prognostic Signature Based on Ferroptosis-Related Genes in Ovarian Cancer
por: Cheng, Zhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3aaddm86lbrjk1qo5fhe43jk3q